Literature DB >> 18068432

B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection.

Andreas M E Koch1, Stefan Zink, Helmut Singer, Sven Dittrich.   

Abstract

AIMS: To assess plasma B-type natriuretic peptide (BNP) levels in patients with univentricular hearts late after volume unloading by total cavopulmonary connection (TCPC).
METHODS: Plasma BNP was measured by sandwich immunoassay in 67 patients after a modified Fontan procedure. BNP levels were compared with age and sex-specific normal values, clinical and echocardiographic data, and results of exercise testing.
RESULTS: BNP had a wide range of 5-290 pg/ml, but was normal in 81% of patients, and median BNP was only 13 pg/ml. There was no difference between males and females, between patients with left or right ventricular morphology, and no correlation was found between BNP and age, post-operative follow-up period, maximum exercise capability, peak oxygen uptake, or blood oxygen saturation. New York Heart Association class I patients had lower BNP than class II patients (p=0.04). Plasma BNP concentration was positively correlated to the number of specific sequelae (r=0.59, p<0.001), and to severity of atrioventricular regurgitation (r=0.38, p=0.002). 5/13 patients with elevated BNP died during follow-up.
CONCLUSION: BNP plasma concentration was normal in the majority of patients up to 15 years after TCPC. Elevated and increasing BNP levels were associated with increased morbidity and late mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18068432     DOI: 10.1016/j.ejheart.2007.11.001

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  11 in total

1.  Increase in N-terminus-pro-B-type natriuretic peptide during exercise of patients with univentricular heart after a total cavopulmonary connection.

Authors:  Alfred Hager; Florian Christov; John Hess
Journal:  Pediatr Cardiol       Date:  2012-02-29       Impact factor: 1.655

2.  Rapid detection of natriuretic peptides by a microfluidic LabChip analyzer with DNA aptamers: Application of natriuretic peptide detection.

Authors:  Ming-Cheng Lin; Jiraporn Nawarak; Tai-Yuan Chen; Hsien-Yu Tsai; Jung-Feng Hsieh; Supachok Sinchaikul; Shui-Tein Chen
Journal:  Biomicrofluidics       Date:  2009-07-30       Impact factor: 2.800

Review 3.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Authors:  Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki
Journal:  Eur Heart J       Date:  2016-01-18       Impact factor: 29.983

4.  Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure.

Authors:  Brian W McCrindle; Victor Zak; Lynn A Sleeper; Stephen M Paridon; Steven D Colan; Tal Geva; Lynn Mahony; Jennifer S Li; Roger E Breitbart; Renee Margossian; Richard V Williams; Welton M Gersony; Andrew M Atz
Journal:  Circulation       Date:  2009-12-21       Impact factor: 29.690

5.  Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles.

Authors:  Kenji Miyamoto; Daiji Takeuchi; Kei Inai; Tokuko Shinohara; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2016-02-08       Impact factor: 2.037

6.  Factors associated with serum brain natriuretic peptide levels after the Fontan procedure.

Authors:  Andrew M Atz; Victor Zak; Roger E Breitbart; Steven D Colan; Sara K Pasquali; Daphne T Hsu; Minmin Lu; Lynn Mahony; Stephen M Paridon; Michael D Puchalski; Tal Geva; Brian W McCrindle
Journal:  Congenit Heart Dis       Date:  2011-03-25       Impact factor: 2.007

7.  Factors associated with serum B-type natriuretic peptide in infants with single ventricles.

Authors:  Ryan J Butts; Victor Zak; Daphne Hsu; James Cnota; Steven D Colan; David Hehir; Paul Kantor; Jami C Levine; Renee Margossian; Marc Richmond; Anita Szwast; Derek Williams; Richard Williams; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2014-02-13       Impact factor: 1.655

Review 8.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

9.  Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.

Authors:  Eva van den Bosch; Sjoerd S M Bossers; Vivian P Kamphuis; Eric Boersma; Jolien W Roos-Hesselink; Johannes M P J Breur; Arend D J Ten Harkel; Livia Kapusta; Beatrijs Bartelds; Arno A W Roest; Irene M Kuipers; Nico A Blom; Laurens P Koopman; Willem A Helbing
Journal:  J Am Heart Assoc       Date:  2021-02-24       Impact factor: 5.501

10.  Aortopulmonary collateral flow is related to pulmonary artery size and affects ventricular dimensions in patients after the fontan procedure.

Authors:  Heiner Latus; Kerstin Gummel; Tristan Diederichs; Anna Bauer; Stefan Rupp; Gunter Kerst; Christian Jux; Hakan Akintuerk; Dietmar Schranz; Christian Apitz
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.